Since in Drosophila and human cells, Src upregulates Stat activity (Cordero et al., 2014; Frame, 2004; Kohlmaier et al., 2014; Read et al., 2004; Sotillos et al., 2013), tumours showing high Bcl6 and Src or Yes1 expression would be predicted to be sensitive to this combined therapeutic regime. The gene discussed is SOAT1; the disease is neoplasm.